Home

Windlas Biotech Ltd PE Ratio

Image

Windlas Biotech Ltd

NSE: WINDLAS

PE

34.7

Last updated on: Jan 23, 2025

Key Highlights

  • The P/E Ratio of Windlas Biotech Ltd is 34.7 as of 23 Jan 15:30 PM .
  • The P/E Ratio of Windlas Biotech Ltd changed from 12 on March 2022 to 18.3 on March 2024 . This represents a CAGR of 15.10% over 3 years.
  • The Latest Trading Price of Windlas Biotech Ltd is ₹ 1016 as of 23 Jan 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Windlas Biotech Ltd

No data available

Company Fundamentals for Windlas Biotech Ltd

Image

Windlas Biotech Ltd

NSE: WINDLAS

Share Price

₹ 1016.8

37.05 (3.78%)

stock direction

Last updated on: Jan 23, 2025

Market Price of Windlas Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Windlas Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
23 Jan 20251016.8
22 Jan 2025979.75
21 Jan 20251000.65
20 Jan 20251011.75
17 Jan 20251006.9
16 Jan 20251002.95
15 Jan 20251005.45
14 Jan 2025986.65
13 Jan 2025924.45
10 Jan 2025988.15

SWOT Analysis Of Windlas Biotech Ltd

Strength

5

che

Weakness

3

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Windlas Biotech Ltd

Asset Value vs Market Value of Windlas Biotech Ltd

Market Value

₹ 0

Asset Value

₹ 0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Windlas Biotech Ltd2125
Sun Pharmaceuticals Industries Ltd440050
Divis Laboratories Ltd155208
Cipla Ltd117197
Torrent Pharmaceuticals Ltd110538
Mankind Pharma Ltd108616

PE Ratio of Windlas Biotech Ltd Explained

Created with Highcharts 11.4.1Share PriceBook value​per share

₹2125

Market cap

₹61

Earnings

34.7X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

Created with Highcharts 11.4.1212528.227.140PE Ratio of Pharmaceuticals Industry over time20202021202220232024

PE Ratio of Top Sectors

Created with Highcharts 11.4.120.317.830.440157.636.9PE Ratio of Top SectorsAutomobileFinanceIT - SoftwarePharmaceuticalsRetailTextiles

Historical Market Cap of Windlas Biotech Ltd

No data available

* All values are in ₹ crore

Historical Revenue, EBITDA and Net Profit of Windlas Biotech Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in ₹ crore

Historical Dividend Payout of Windlas Biotech Ltd

No data available

* All values are in %

About Windlas Biotech Ltd

  • Windlas Biotech Limited (formerly known as Windlas Biotech Private Limited) was incorporated in 2001.
  • The Company converted from a Private Limited Company to a Public Limited Company and the name of the Company was changed to Windlas Biotech Limited'.
  • A fresh Certificate of Incorporation dated April 15, 2021, granted by the Registrar of Companies, Uttarakhand at Dehradun. The Company is engaged in manufacturing and trading of pharmaceutical products.
  • TheIR manufacturing facilities are located at Dehradun in Uttarakhand.
  • It also has a sales force and distribution network spread across 14 states.

Windlas Biotech Ltd News Hub

Windlas Biotech consolidated net profit rises 11.68% in the June 2024 quarter

Net profit of Windlas Biotech rose 11.68% to Rs 13.48 crore in the quarter ended June 2024 as agains

Read more

13 Aug 24

Windlas Biotech to declare Quarterly Result

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 13 August 2024. Powe

Read more

03 Aug 24

Windlas Biotech schedules AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

03 Sept 24

Windlas Biotech to hold AGM

Windlas Biotech announced that the Annual General Meeting (AGM) of the company will be held on 24 Se

Read more

03 Sept 24

Product Composition by Percentage (Revenue)

Created with Highcharts 11.4.1

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Windlas Biotech Ltd

What is the current PE Ratio of Windlas Biotech Ltd?

The Current PE Ratio of Windlas Biotech Ltd is 34.7 as on 23 Jan 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 23 Jan 2025.

What was the PE Ratio of Windlas Biotech Ltd last year?

The PE Ratio of Windlas Biotech Ltd was 11.06 last year, now the PE ratio is 34.7, showing a year-on-year growth of 213.7%.

What does the PE Ratio of Windlas Biotech Ltd indicate about its stock?

The PE Ratio of Windlas Biotech Ltd is 34.7. This ratio indicates that investors are willing to pay 34.7 times the earnings per share for each share of Windlas Biotech Ltd.

What is the PE Ratio Growth of Windlas Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Windlas Biotech Ltd grew by 213.7% whereas, the EPS ratio grew by 15.8.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions